Capital Investment Counsel Inc Has $390,000 Position in The Clorox Company (NYSE:CLX)

Capital Investment Counsel Inc reduced its stake in The Clorox Company (NYSE:CLX) by 18.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,400 shares of the company’s stock after selling 536 shares during the period. Capital Investment Counsel Inc’s holdings in Clorox were worth $390,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Insight Folios Inc grew its stake in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after acquiring an additional 63 shares in the last quarter. HCR Wealth Advisors grew its stake in shares of Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after acquiring an additional 68 shares in the last quarter. Empower Advisory Group LLC grew its stake in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after acquiring an additional 78 shares in the last quarter. Aviance Capital Partners LLC grew its stake in shares of Clorox by 2.7% in the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after acquiring an additional 80 shares in the last quarter. Finally, Lindbrook Capital LLC grew its stake in shares of Clorox by 9.9% in the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after acquiring an additional 88 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. DA Davidson reduced their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Barclays increased their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Finally, StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $158.21.

Clorox Stock Up 1.2 %

Shares of NYSE CLX opened at $152.93 on Friday. The company has a 50 day simple moving average of $158.11 and a 200 day simple moving average of $159.68. The firm has a market cap of $18.84 billion, a PE ratio of 41.78, a price-to-earnings-growth ratio of 2.54 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period last year, the firm posted $2.16 earnings per share. On average, research analysts forecast that The Clorox Company will post 7.15 EPS for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.